Clinical Epigenetics

Clinical Epigenetics

临床表观遗传学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Clinical Epigenetics》是由BioMed Central出版社于2010年创办的英文国际期刊(ISSN: 1868-7075,E-ISSN: 1868-7083),该期刊长期致力于遗传学领域的创新研究,主要研究方向为Developmental Biology-Biochemistry, Genetics and Molecular Biology。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表遗传学领域等方向的原创性研究为核心(研究类文章占比90.10%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在192篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical Epigenetics审稿周期约为 12 Weeks 。该刊近年未被列入国际预警名单,年发文量约192篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 192 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
GENETICS & HEREDITY 遗传学 ONCOLOGY 肿瘤学
2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GENETICS & HEREDITY 遗传学 ONCOLOGY 肿瘤学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GENETICS & HEREDITY SCIE Q1 29 / 191

85.1%

学科:ONCOLOGY SCIE Q1 70 / 322

78.4%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GENETICS & HEREDITY SCIE Q1 33 / 191

82.98%

学科:ONCOLOGY SCIE Q1 64 / 322

80.28%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:8.9 SJR:1.727 SNIP:1.019
学科类别 分区 排名 百分位
大类:Medicine 小类:Genetics (clinical) Q1 13 / 99

87%

大类:Medicine 小类:Developmental Biology Q1 14 / 82

83%

大类:Medicine 小类:Genetics Q1 60 / 347

82%

大类:Medicine 小类:Molecular Biology Q1 96 / 410

76%

期刊发文

  • Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study: A prospective diagnostic study

    Author: Yuan, Zixu; Chen, Wenle; Liu, Duo; Qin, Qiyuan; Grady, William M.; Fichera, Alessandro; Wang, Huaiming; Hou, Ting; Lv, Xinze; Li, Chanhe; Wang, Hui; Cai, Jian

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-023-01479-9

  • Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA

    Author: Guo, Ping; Zheng, Hailing; Li, Yihan; Li, Yuntong; Xiao, Yue; Zheng, Jin; Zhu, Xingqiang; Xu, Huan; He, Zhi; Zhang, Qian; Chen, Jinchun; Qiu, Mingshan; Jiang, Min; Liu, Pingguo; Chen, Hongliang

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-022-01420-6

  • Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

    Author: Yu, Fenglei; Huang, Xiaojie; Zhou, Danting; Zhao, Zhenyu; Wu, Fang; Qian, Banglun; Wang, Qiang; Chen, Juan; Liang, Qingchun; Jiang, Yi; Ding, Qi; He, Qiongzhi; Tang, Jingqun; Wang, Xiang; Liu, Wenliang; Chen, Chen

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-023-01422-y

  • Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cells

    Author: Li, Bin; Ren, Baoqing; Ma, Gang; Cai, Fenglin; Wang, Pengliang; Zeng, Yi; Liu, Yong; Zhang, Li; Yang, Yang; Liang, Han; Zhang, Rupeng; Deng, Jingyu

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-023-01425-9

  • Azithromycin attenuates wheezing after pulmonary inflammation through inhibiting histone H3K27me3 hypermethylation mediated by EZH2

    Author: Wu, Shuqi; Tian, Xiaochun; Mao, Qian; Peng, Chang

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-023-01430-y

  • Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients

    Author: Tang, Zengwei; Yang, Yuan; Zhang, Qi; Liang, Tingbo

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-022-01413-5

  • The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma

    Author: Wang, Xiaonan; Zhu, Wancui; Long, Qian; Chen, Enni; Sun, Haohui; Li, Xiaodi; Xu, Hailin; Li, Weizhao; Dong, Pei; He, Liru; Chen, Miao; Deng, Wuguo

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-023-01426-8

  • E2F1 combined with LINC01004 super-enhancer to promote hepatocellular carcinoma cell proliferation and metastasis

    Author: Li, Jingxuan; Wang, Jiying; Wang, Yanping; Zhao, Xueyan; Su, Tao

    Journal: CLINICAL EPIGENETICS. 2023; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s13148-023-01428-6